ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,906.94
      -1.07%
      US Tech 100
      20,599.96
      -1.45%
      Dow Jones
      42,573.73
      -0.97%
      Brent Oil
      74.105
      0.65%
      Bitcoin
      92,589.98
      -0.99%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Kromek Group Plc (KMK) Quote

      Kromek Group Plc

      Kromek Group Plc (KMK)

      LSE
      5.05
      0.00
      (0.00%)
      Closed December 30 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      5.05
      Bid
      4.90
      Ask
      5.20
      Volume
      384,979
      5.05 Day's Range 5.05
      4.75 52 Week Range 8.25
      Market Cap
      32.398M
      Previous Close
      5.05
      Open
      5.05
      Last Trade
      20512
      @
      4.9111
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,382,315
      Shares Outstanding
      641,550,000
      Dividend Yield
      -
      PE Ratio
      -9.90
      Earnings Per Share (EPS)
      -0.01
      Revenue
      19.4M
      Net Profit
      -3.29M

      About Kromek Group Plc

      Sector
      Miscellaneous Metal Ores,nec
      Industry
      Miscellaneous Metal Ores,nec
      Website
      www.kromek.com
      Headquarters
      Durham, Gbr
      Founded
      -
      Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 5.05p. Over the last year, Kromek shares have traded in a share price range of 4.75p to 8.25p.

      Kromek currently has 641,550,000 shares outstanding. The market capitalization of Kromek is £32.40 million. Kromek has a price to earnings ratio (PE ratio) of -9.90.

      Ask ADVFN Intelligence (AI)

      KMK Latest News

      More News

      Kromek Group PLC Result of AGM

      Kromek Group PLC 13 December 2024   13 December 2024   Kromek Group plc ("Kromek" or the "Group")   Result of AGM   Kromek (AIM: KMK), a leading developer of radiation and bio-detection...

      December 13 2024
      RNS Regulatory News

      Kromek Group PLC Notice of AGM and Publication of Annual Report

      Kromek Group PLC 18 November 2024   18 November 2024   Kromek Group plc ("Kromek" or the "Group")   Notice of AGM and Publication of Annual Report   Kromek (AIM: KMK), a leading developer of...

      November 18 2024
      RNS Regulatory News

      Kromek narrows annual loss as geopolitical insecurity drives demand

      Kromek PLC on Monday said its annual loss narrowed its most recent financial year, following a reduction in expenses ...

      October 28 2024
      Alliance News

      Kromek Group PLC Final Results and Publication of Annual Report

      Kromek Group PLC 28 October 2024   28 October 2024 Kromek Group plc ("Kromek" or the "Company" or the "Group")   Final Results and Publication of Annual Report   Kromek (AIM: KMK), a leading...

      October 28 2024
      RNS Regulatory News

      Kromek Group PLC Financing Update

      Kromek Group PLC 28 October 2024   28 October 2024   Kromek Group plc  ("Kromek" or the "Company")    Financing Update   Kromek (AIM: KMK), a leading developer of radiation and bio-detection...

      October 28 2024
      RNS Regulatory News

      Kromek Group PLC Update on Full Year Results

      Kromek Group PLC 30 September 2024   30 September 2024   Kromek Group plc ("Kromek" or the "Group")   Update on Full Year Results   Kromek (AIM: KMK), a leading developer of radiation and...

      September 30 2024
      RNS Regulatory News

      Kromek Group PLC Kromek selected for UK Government Framework

      Kromek Group PLC 23 September 2024   23 September 2024   Kromek Group plc ("Kromek" or the "Group")   Kromek selected for UK Government Radiological Nuclear Detection Framework   Kromek (AIM:...

      September 23 2024
      RNS Regulatory News

      Kromek wins GBP2 million contract with UK Ministry of Defence

      Kromek Group PLC on Monday announced it has won a contract worth GBP2.0 million from the UK Ministry of Defence for t ...

      September 16 2024
      Alliance News

      Kromek Group PLC Kromek awarded £2.0m contract from UK MOD

      Kromek Group PLC 16 September 2024   16 September 2024   Kromek Group plc ("Kromek" or the "Group")   Kromek awarded £2.0m contract from UK Ministry of Defence   Kromek (AIM: KMK), a leading...

      September 16 2024
      RNS Regulatory News

      Kromek Group PLC Holding(s) in Company

      Kromek Group PLC 21 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD7V5D43 Issuer Name KROMEK GROUP PLC UK or Non-UK Issuer UK 2. Reason for...

      August 21 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.05-0.9803921568635.15.255.052322165.08026093DE
      4-0.55-9.821428571435.65.64.7757164355.17749761DE
      12-2.2-30.34482758627.257.64.77513823156.18497754DE
      26-2.2-30.34482758627.257.64.77510935246.18717344DE
      520.255.208333333334.88.254.7510873396.37016698DE
      156-10.425-67.36672051715.47517.93.1512112067.30753636DE
      260-20.95-80.57692307692627.253.15139618611.49859827DE

      KMK - Frequently Asked Questions (FAQ)

      What is the current Kromek share price?
      The current share price of Kromek is 5.05p
      How many Kromek shares are in issue?
      Kromek has 641,550,000 shares in issue
      What is the market cap of Kromek?
      The market capitalisation of Kromek is GBP 32.4M
      What is the 1 year trading range for Kromek share price?
      Kromek has traded in the range of 4.75p to 8.25p during the past year
      What is the PE ratio of Kromek?
      The price to earnings ratio of Kromek is -9.9
      What is the cash to sales ratio of Kromek?
      The cash to sales ratio of Kromek is 1.67
      What is the reporting currency for Kromek?
      Kromek reports financial results in GBP
      What is the latest annual turnover for Kromek?
      The latest annual turnover of Kromek is GBP 19.4M
      What is the latest annual profit for Kromek?
      The latest annual profit of Kromek is GBP -3.29M
      What is the registered address of Kromek?
      The registered address for Kromek is NETPARK, THOMAS WRIGHT WAY, SEDGEFIELD, DURHAM, TS21 3FD
      What is the Kromek website address?
      The website address for Kromek is www.kromek.com
      Which industry sector does Kromek operate in?
      Kromek operates in the MISCELLANEOUS METAL ORES,NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CLAICel Ai Plc
      0.085p
      (41.67%)
      		20.65M
      ZEDZenova Group Plc
      0.675p
      (22.73%)
      		4.33M
      GFINGfinity Plc
      0.07p
      (21.74%)
      		118M
      SDXSdx Energy Plc
      0.424p
      (21.14%)
      		28.44M
      OBDOxford Biodynamics Plc
      1.45p
      (20.83%)
      		1.79M
      QUIZQuiz Plc
      0.745p
      (-15.82%)
      		5.25M
      SRESSunrise Resources Plc
      0.0275p
      (-15.38%)
      		43.75M
      PPSProton Motor Power Systems Plc
      0.275p
      (-15.38%)
      		401.8k
      ALTEAlteration Earth Plc
      10.75p
      (-14.00%)
      		1.87M
      SYMESupply@me Capital Plc
      0.0034p
      (-13.92%)
      		513.5M
      TRPTower Resources Plc
      0.037p
      (8.82%)
      		991.59M
      SYMESupply@me Capital Plc
      0.0034p
      (-13.92%)
      		513.5M
      NTVONativo Resources Plc
      0.002p
      (0.00%)
      		399.34M
      PREMPremier African Minerals Limited
      0.044p
      (-12.87%)
      		296.47M
      NTOGNostra Terra Oil And Gas Company Plc
      0.027p
      (3.85%)
      		273.27M

      Discussion

      View Full Feed
      juicyjuice10002 juicyjuice10002 33 seconds ago
      https://sinvestsllc.com/fannie-mae-fnma-price-target-90/
      FNMA
      Number sleven Number sleven 39 seconds ago
      JRoon, Oxylanthanum carbonate is not chemically identical to Lanthanum carbonate. It has an extra oxygen atom. That makes it a new drug. I don't know if kiwi is ignorant of this or trying to mislead people.
      Sleven,
      AMRN
      OrbitWitch50 OrbitWitch50 47 seconds ago
      Did anyone else catch on page ten that they wrote sky quarry instead of AWS/ZHUD as a strong buy?

      Fun little typo but we'll be moving up soon. Where's Babud and his hype when you need him?
      ZHUD
      solong solong 2 minutes ago
      LOL, with all due respect...this shouldn't be trading at all. NOT 1 mil volumes per day. On the plus side, they are not trying to pump this by putting out superfluous PRs.

      Based on what they've said to us, we need a S-1 Registration for Global (putting up the $5mil vehicle) - why wo
      SYIN
      Militia Man Militia Man 2 minutes ago
      I am up again 250% again. Is that certifiable too? lol FOCUS
      PHIL
      mrwrn2010 mrwrn2010 3 minutes ago
      Is there any price that will make you happy? Seem pretty bitter in general.
      ELTP
      NeutrinoKid NeutrinoKid 3 minutes ago
      Market report from Insight Ace Analytics mentions RespireRx:

      Cannabinoid Derived Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Natural (Plant-derived), Synthetic Cannabinoid), By Molecule Type (Cannabinoid Receptor Type 1 (CB1), Cannabinoid Receptor Type 2 (CB
      RSPI
      hedge_fun hedge_fun 3 minutes ago
      Kongsberg GeoAcoustics GeoChirp 3D sub-bottom profiler delivered to China

      GeoChirp 3D high resolution sub-bottom profiler provides three dimensional acoustical images of shallow sub-seabed structures and buried objects. It transfers the well-established principles of conventional 3D r
      SFRX
      trunkmonk trunkmonk 3 minutes ago
      Markets cant function on doubt and uncertainties, all Bill did was more of the same he has done for 10 years, put out the facts, timing, conditions, and insight. we now have more certainty here then we did yesterday, the plan is there, as time goes on, Bill, the insider, sees better tomorrows. its p
      FNMA
      Go Hawks13 Go Hawks13 4 minutes ago
      He doesn’t get paid to read just to promote!!
      FCEL
      manibiotech manibiotech 4 minutes ago
      Don't need investment advice from you .
      I get it accountability is not looked upon nicely on this board . But that's your prerogative . 
      NWBO
      pos_stock_hoarder pos_stock_hoarder 4 minutes ago
      Espionage!
      https://youtu.be/4-LvTH2J88k
      dbob dbob 5 minutes ago
      there are a few serious people on this thread. You are not one of them. Your a no good loud mouth who know's nothing. If the stock goes to ..0009 i don't care. If it goes to .0008 i don't care. I only care about the end result. This will work out for all that are patient. Your attitude stinks.
      HIRU
      kenjiroo kenjiroo 5 minutes ago
      good post ... all in a nutshell .. ST3 is a big liar .. you have been to gentle. happy NY to all longs ... if nothing changes medio 2025 .. it's time to don't waist anymore time in this stock or this board. trowing the towel. I kinda had it with ST3 AKA Mighty
      TPTW
      QuantumMaestro53 QuantumMaestro53 6 minutes ago
      There were and are multiple issues with the UBQU and IO deal:

      1. Neither side did their due diligence in the other.
      2. I’ll say it again, there was no acquisition of IO. Had there been, UBQU would have been named in the multiple lawsuits.
      3. With no actual acquisition,
      UBQU
      GolfnutBoston GolfnutBoston 6 minutes ago
      MTi must do about $2 million a year in revenue?
      Happy New Year folks. Hopefully 2025 is better for AFFU share price. Wishful thinking I know. 
      AFFU
      Kracker Jones Kracker Jones 6 minutes ago
      When's the R/S?
      GRLF
      exwannabe exwannabe 6 minutes ago
      Those attacking Northwest Biotherapeutics have blood on their hands.
      If -L actually works then supporters of management have blood on their hands for not only delaying the start of a proper trial for 7 years or so, but diverting funds intended for it to L's CDMO.
      CDMO
      TrendTrade2016 TrendTrade2016 6 minutes ago
      LPSN READY TO FLY
      LPSN
      Yachts Yachts 6 minutes ago
      I'm not a lawyer, but surely if a company raises funds for a specific project and fails to spend those funds on said project, that constitutes fraud. Would not the Board and management team then be guilty of fraud and thus be liable to the shareholders?
      SDRC
      LA4321 LA4321 6 minutes ago
      who knows if this piece was put out by a new "awareness group"------who knows if there is a new "awareness group"------might have been a prudent move to present this along w the news of a new name/symbol---------heres a deep dark secret--------not that big a deal TO CHANGE NAME/SYMBOL..........
      DUTV
      newmedman newmedman 7 minutes ago
      cdn.bsky.app/img/feed_thumbnail/plain/did:plc:qigfidlbmgo7pbud55ltckl6/bafkreihyf3v2ochmqv4kestn5xb7t6reh3jujebr5ftl2q3bgu3ariypbu@jpeg

      cdn.bsky.app/img/feed_thumbnail/plain/did:plc:vxkxu65awa3ocjpiqmmrxnt2/bafkreiephmguptblkn6r5fklemisrg7oog2s2zgwmeumfn4if4esgt3lre@jpeg
      BullNBear52 BullNBear52 7 minutes ago
      It's one thing on weekends I love to have with the chips by the same brand. Heat it up in the microwave and dip away during football games.

      Though I hear fondue is making a comeback.
      While both fondue and raclette are Swiss dishes featuring melted cheese, the key difference is
      WandererHero90 WandererHero90 7 minutes ago
      I have not been invested here for years. I started building my position in 2023 and consider myself fortunate to have had the recent opportunity to add at under $2/share. I'm sure I'm not alone. New technology takes time to develop, time to vett, time to gain acceptance, and time to commercialize. L
      LWLG

      Your Recent History

      LSE
      KMK
      Kromek
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads